NCT02924038 2024-06-14A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)University of California, San FranciscoPhase 1 Terminated14 enrolled 10 charts